MTEC Solicitation Summary: Fiscal Year 2026 Multi-Topic Request for Project Proposals

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DEFENSE HEALTH AGENCY

Contract Value

Not provided

Codes & Classification
Solicitation Number

MTEC-26-04-MultiTopic

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Classification Code

AN43

Additional Details
Set Aside

NONE

Place of Performance

Frederick, Maryland, UNITED STATES

SourceSAM
Documents2
The Defense Health Agency (DHA), through the Medical Technology Enterprise Consortium (MTEC), has issued a Special Notice summarizing the Fiscal Year 2026 Multi-Topic Request for Project Proposals (RPP), procurement identifier MTEC-26-04-MultiTopic. This solicitation seeks innovative medical prototype solutions and knowledge products that address a diverse array of focus areas critical to military health and operational readiness. The RPP is designed to support the modernization of medical capabilities for the U.S. military, ensuring force readiness and enhancing the health and performance of warfighters in future multi-domain conflicts. **Purpose, Scope, and Intended Outcomes** The primary objective of this RPP is to solicit and fund prototype projects that deliver tangible, military-relevant medical solutions. These solutions may encompass medical devices, drugs, biologics, clinical techniques, and knowledge products, all aimed at addressing specific challenges faced by military personnel in operational environments. The intended outcomes are to advance the development and transition of cutting-edge medical technologies and practices that can be rapidly deployed to protect, treat, and optimize the health and performance of service members across the full spectrum of military operations. **Key Requirements, Objectives, and Expected Deliverables** Offerors are required to submit Enhanced White Paper proposals that address only one of the defined Focus Areas. Each proposal must demonstrate clear military relevance, fit the definition of a prototype (i.e., not be exploratory and be supported by preliminary data), meet a minimum Technology or Knowledge Readiness Level (TRL/KRL) of 3, and represent a new submission not previously proposed to MTEC within the past two years. The RPP encompasses sixteen Focus Areas, each with distinct objectives, including but not limited to: - Prevention of harmful behaviors and promotion of service member fitness - Reducing barriers to help-seeking for at-risk populations - Prophylactic and therapeutic solutions for battlefield wound infections and sepsis - Knowledge products to optimize clinical guidelines for infection prevention - Prevention and treatment of bacterial diarrhea, dengue fever, and emerging infectious diseases - Musculoskeletal injury interventions and pain management solutions - Development of non-addictive analgesics and advanced anesthesia systems for austere environments - Technologies for monitoring blast and blunt impact exposure - (Amendment 01) Development of a multisite clinical biomarker platform for trauma-related lung and kidney failure Detailed requirements, including minimum TRL/KRL and data submission expectations, are provided in Section 3 of the full RPP, available on the MTEC website. **Contracting Entity, Location, and Classification Codes** The contracting entity for this opportunity is the Defense Health Agency (DHA), a federal office under the Department of Defense. The place of performance is Frederick, Maryland, United States. The procurement is classified under NAICS code 541715 (Research and Development in the Physical, Engineering, and Life Sciences, except Nanotechnology and Biotechnology), with Product Service Code AN43. **Procurement Type, Set-Aside, and Special Considerations** This is a Special Notice for a competitive solicitation under the authority of 10 U.S.C. § 4022, which allows the Department of Defense to carry out certain prototype projects. There is no set-aside for this opportunity; all qualified entities are eligible to apply. The acquisition approach utilizes a two-stage Enhanced White Paper process: initial white paper submission and evaluation, followed by invitation-only submission of full cost proposals for selected projects. Offerors are encouraged, though not required, to consider teaming with other MTEC members to address the full scope of technical requirements. MTEC provides resources and support for team building through its member portal. **Funding and Period of Performance** Funding levels, period of performance, and the number of anticipated awards vary by Focus Area and are contingent upon federal funding availability. Historically, initial MTEC awards average between $2.0 and $3.5 million over a 2-3 year period. The selection process is highly competitive, based on technical merit, programmatic considerations, and available funds. There is potential for non-competitive follow-on tasks for successful projects, subject to government review and milestone achievement. **Contact Information and Additional Resources** For further information or teaming assistance, interested parties should contact Dr. Chuck Hutti, MTEC Senior Technical Program Manager, at [email protected]. The full solicitation, including detailed requirements and submission instructions, is available at https://mtec-sc.org/solicitations. Additional background on MTEC and its mission can be found at https://mtec-sc.org/. **Summary for Contractors** This opportunity is well-suited for organizations with demonstrated capabilities in medical research and development, particularly those with experience in military health, prototype development, and translational science. The broad scope of focus areas allows for a wide range of technical solutions, but proposals must be mature, data-driven, and directly relevant to military operational needs. Contractors should carefully review the full RPP to ensure alignment with the specific requirements and readiness levels for their chosen focus area. The competitive nature of the solicitation and the potential for significant follow-on work make this an attractive opportunity for qualified entities seeking to contribute to the advancement of military medical technology.